CH Boehringer Sohn AG & Co KG is the parent company of the Boehringer Ingelheim pharmaceutical group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, in Germany. Today, they are a global group of companies producing pharmaceuticals for the worldwide market. With reported revenue of $17.9 billion in 2017, they are one of the largest pharmaceutical companies in the world, remaining in the hands of the Boehringer, Liebricht and von Baumbach families. Specifically, the company’s research focuses around the areas of respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. One of its early commercial successes was the reproduction of lactic acid created by the human body, which was quickly made available for sale. In 1917, future Nobel Prize winner Professor Heinrich Otto Wieland set up the company’s research department. In the years following WWII, Dr. Karl Thomae GmbH re-opened in Biberach an der Riss with a staff of 70 – the foundation for its future expansion. In 1955, it acquired Pfizer’s veterinary programme and, by 1966, a subsidiary had been established in Greece: Boehringer Ingelheim Hellas. Today, the company has 146 subsidiaries around the globe. The company’s largest site is near Mainz, and its corporate headquarters are in Frankfurt. It employs more than 50,000 people with a long list of successful products in prescription medicine, consumer healthcare and animal health.
- Family name: Boehringer family
- Sector: Life Sciences
- Founded: 1885
- Founder: Albert Boehringer
- Country: Germany
- Revenue: 16.1
- Employees: 47,501
- Website: boehringer-ingelheim.com
Connections
Also on Tharawat